|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 117.67 USD | +0.84% |
|
+0.36% | +19.14% |
| 07-23 | JPMorgan Adjusts Price Target on Incyte to $110 From $105, Maintains Neutral Rating | MT |
| 07-22 | Morgan Stanley Adjusts Price Target on Incyte to $104 From $103, Maintains Equalweight Rating | MT |
Company Valuation: Incyte Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 16,213 | 17,869 | 14,072 | 13,306 | 19,391 | 23,508 | - | - |
| Change | - | 10.21% | -21.25% | -5.44% | 45.73% | 21.23% | - | - |
| Enterprise Value (EV) 1 | 13,865 | 14,630 | 10,416 | 11,148 | 16,293 | 19,501 | 17,582 | 15,383 |
| Change | - | 5.52% | -28.81% | 7.03% | 46.15% | 19.69% | -9.84% | -12.5% |
| P/E | 17.2x | 52.8x | 23.7x | 460x | 15.4x | 57x | 15.3x | 14.2x |
| PBR | 4.32x | 4.09x | 2.71x | 3.88x | 3.79x | 4.21x | 2.99x | 2.23x |
| PEG | - | -0.8x | 0.3x | -4.9x | 0x | -0.8x | 0x | 1.77x |
| Capitalization / Revenue | 5.43x | 5.26x | 3.81x | 3.14x | 3.77x | 4.09x | 3.79x | 3.62x |
| EV / Revenue | 4.64x | 4.31x | 2.82x | 2.63x | 3.17x | 3.39x | 2.83x | 2.37x |
| EV / EBITDA | 21.5x | 24.5x | 14.8x | 22.2x | 9.53x | 25.3x | 7.53x | 6.38x |
| EV / EBIT | 23.7x | 25.2x | 16.8x | 26.9x | 10.1x | 27.4x | 7.56x | 5.95x |
| EV / FCF | 24.4x | 16.4x | 22.4x | 44.8x | - | 26.8x | 9.5x | 8.45x |
| FCF Yield | 4.1% | 6.1% | 4.45% | 2.23% | - | 3.73% | 10.5% | 11.8% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 4.27 | 1.52 | 2.65 | 0.15 | 6.41 | 2.066 | 7.678 | 8.295 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 2,986 | 3,395 | 3,696 | 4,241 | 5,141 | 5,748 | 6,205 | 6,496 |
| EBITDA 1 | 643.6 | 597.7 | 703.2 | 503.1 | 1,709 | 770.4 | 2,336 | 2,413 |
| EBIT 1 | 585.8 | 579.4 | 620.5 | 413.9 | 1,616 | 712.3 | 2,325 | 2,584 |
| Net income 1 | 948.6 | 340.7 | 597.6 | 32.62 | 1,287 | 426.4 | 1,592 | 1,725 |
| Net Debt 1 | -2,348 | -3,239 | -3,656 | -2,158 | -3,098 | -4,007 | -5,927 | -8,125 |
| Reference price 2 | 73.40 | 80.32 | 62.79 | 69.07 | 98.77 | 117.67 | 117.67 | 117.67 |
| Nbr of stocks (in thousands) | 220,891 | 222,475 | 224,109 | 192,650 | 196,323 | 199,782 | - | - |
| Announcement Date | 2/8/22 | 2/7/23 | 2/13/24 | 2/10/25 | 2/10/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 56.96x | 3.39x | 25.31x | -.--% | 23.51B | |
| 17.35x | 3.71x | 9.57x | 0.59% | 66.74B | |
| 26.36x | 5.45x | 16.03x | 0.6% | 53.32B | |
| 37.26x | 12.6x | 24.05x | -.--% | 48.12B | |
| -42.39x | 3.06x | 9.03x | 3.57% | 38.25B | |
| 25.06x | 3.49x | 11.87x | -.--% | 29.85B | |
| -6.24x | 8.61x | -5.3x | -.--% | 21.45B | |
| 64.96x | 6.38x | 43.91x | -.--% | 19.97B | |
| -37.77x | 18x | -49.29x | -.--% | 16.47B | |
| 24.05x | 5.15x | 13.48x | -.--% | 16.38B | |
| Average | 16.56x | 6.99x | 9.87x | 0.48% | 33.41B | |
| Weighted average by Cap. | 17.23x | 6.40x | 12.33x | 0.62% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- INCY Stock
- Valuation Incyte Corporation
Select your edition
All financial news and data tailored to specific country editions
